Hypertrophic cardiomyopathy trials in Austria

3 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  Where

  Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna

  Age

  18 years and over

  People

  1,700 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT05489705
• No phaseTaking people
  Austrian Hypertrophic Cardiomyopathy Registry

  Where

  Braunau am Inn, Graz, Innsbruck, Linz, Salzburg, Sankt Johann in Tirol, Sankt Pölten, Schwarzach im Pongau, Vienna, Wels-Grieskirchen, Wiener Neustadt

  Age

  18 years and over

  People

  1,000

  Run by

  Medical University of Graz

  See details and how to joinNCT06368518
• No phaseTaking people
  Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

  Where

  Vienna

  Age

  18 years and over

  People

  20

  Run by

  Medical University of Vienna

  See details and how to joinNCT07150299